23/04/2014 12:11:45 Free Membership Login

Amylin is Said To Draw First-Round Bids of Up to $29/Share -Bloomberg

Date : 06/05/2012 @ 9:10AM
Source : Dow Jones News
Stock : Sanofi (SAN)
Quote : 77.05  -0.08 (-0.10%) @ 11:35AM
Sanofi share price Chart

Amylin is Said To Draw First-Round Bids of Up to $29/Share -Bloomberg

Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart

2 Years : From Apr 2012 to Apr 2014

Click Here for more Amylin Pharmaceuticals, Inc. (MM) Charts.

Diabetes drug maker Amylin Pharmaceuticals Inc. (AMLN) drew four first-round bids valuing the company at $25 to $29 a share, with Pfizer Inc. (PFE) dropping out of the process, Bloomberg News reported Monday on its website, citing people with knowledge of the process.

AstraZeneca Plc (AZN), Sanofi (SNY), Merck & Co. (MRK) and Bristol-Myers Squibb Co. (BMY) submitted offers, with revised offers due by the end of the month and a sale likely in July, two people told Bloomberg.

Representatives for Amylin, Merck, Bristol-Myers, AstraZeneca, Sanofi and Pfizer declined comment to Bloomberg.

Full story at: www.bloomberg.com/news/2012-06-04/amylin-said-to-draw-bids-of-25-to-29-a-share-in-first-round.html

-Dow Jones Newswires; 212-416-2900



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us 140423 12:11